VIRIOS THERAPEUTICS INC (VIRI) Stock Price, Quote, News and Overview
NASDAQ:VIRI - Nasdaq - US92829J1043 - Common Stock - Currency: USD
VIRI Quote, Performance and Key Statistics
0.155
+0.02 (+12.4%)
The current stock price of VIRI is 0.155 USD. In the past month the price decreased by -11.68%. In the past year, price decreased by -80.5%.
VIRI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About VIRI
Company Profile
Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The company is headquartered in Alpharetta, Georgia. The company went IPO on 2020-12-17. The firm is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia (FM) and Long-COVID (LC). Its lead candidate, IMC-1, is a novel, proprietary, fixed dose combination of famciclovir and celecoxib. IMC-1 represents a novel combination, dual mechanism antiviral therapy designed to synergistically suppress herpes virus activation and replication, with the end goal of reducing viral mediated disease burden. IMC-2 is a combination of valacyclovir and celecoxib that is believed to have specific activity against Epstein-Barr virus (herpesvirus HHV-4), as well as other herpesviruses. IMC-1 and IMC-2 combine two specific mechanisms of action purposely designed to inhibit herpesvirus activation and replication, thereby converting activated herpesvirus back to dormancy and/or by keeping the herpesvirus in a latent or dormant state.
Company Info
VIRIOS THERAPEUTICS INC
44 Milton Avenue
Alpharetta GEORGIA US
Employees: 4
Company Website: https://www.virios.com/
Phone: 18666208655
VIRIOS THERAPEUTICS INC / VIRI FAQ
What is the stock price of VIRIOS THERAPEUTICS INC today?
The current stock price of VIRI is 0.155 USD. The price increased by 12.4% in the last trading session.
What is the ticker symbol for VIRIOS THERAPEUTICS INC stock?
The exchange symbol of VIRIOS THERAPEUTICS INC is VIRI and it is listed on the Nasdaq exchange.
On which exchange is VIRI stock listed?
VIRI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VIRIOS THERAPEUTICS INC stock?
8 analysts have analysed VIRI and the average price target is 1.43 USD. This implies a price increase of 821.29% is expected in the next year compared to the current price of 0.155. Check the VIRIOS THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VIRIOS THERAPEUTICS INC worth?
VIRIOS THERAPEUTICS INC (VIRI) has a market capitalization of 172.05K USD. This makes VIRI a Nano Cap stock.
How many employees does VIRIOS THERAPEUTICS INC have?
VIRIOS THERAPEUTICS INC (VIRI) currently has 4 employees.
Should I buy VIRIOS THERAPEUTICS INC (VIRI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VIRI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VIRI, evaluating the profitability, health, valuation and growth aspects
- VIRIOS THERAPEUTICS INC (VIRI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIRIOS THERAPEUTICS INC (VIRI) Sales and EPS estimates to see what analysts future expectations are.
- VIRIOS THERAPEUTICS INC (VIRI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIRIOS THERAPEUTICS INC (VIRI) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIRIOS THERAPEUTICS INC (VIRI) Stock Chart to make your own analysis
- VIRIOS THERAPEUTICS INC (VIRI) Latest news and press-releases to stay up to date.
Does VIRIOS THERAPEUTICS INC (VIRI) stock pay dividends?
VIRI does not pay a dividend.
When does VIRIOS THERAPEUTICS INC (VIRI) report earnings?
VIRIOS THERAPEUTICS INC (VIRI) will report earnings on 2024-11-11, before the market open.
What is the Price/Earnings (PE) ratio of VIRIOS THERAPEUTICS INC (VIRI)?
VIRIOS THERAPEUTICS INC (VIRI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.24).
VIRI Technical Analysis
VIRI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VIRI. While VIRI seems to be doing ok healthwise, there are quite some concerns on its profitability.
VIRI Financial Highlights
Over the last trailing twelve months VIRI reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS increased by 56.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.66% | ||
| ROE | -168.89% | ||
| Debt/Equity | 0 |
VIRI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to VIRI. The Buy consensus is the average rating of analysts ratings from 8 analysts.